Significant Revenue Growth
NEXGEL reported a 100% year-over-year increase in revenue for Q2 2025, totaling approximately $2.9 million, driven by consumer demand and new contract manufacturing agreements.
Improved Gross Margins
Gross margins for Q2 2025 were 43.6%, more than double the 20.3% reported in Q2 2024, reflecting improved profitability.
Contract Manufacturing Surge
Contract manufacturing revenue increased by 103% year-over-year, reaching $863,000, due to strong demand from existing customers and new global corporations.
Successful New Product Launches
NEXGEL launched several new products, including Silly George beauty products and Kenkoderm skincare, contributing to a 95% year-over-year increase in consumer product revenue.
Strategic Partnerships and Funding
NEXGEL received $1 million in non-dilutive funding from STADA to support product launches and marketing, strengthening their financial position.
Positive EBITDA Guidance
The company remains confident in achieving positive EBITDA for 2025, supported by strong revenue growth and strategic partnerships.